Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, ACC

TPC and WhiteSpace Health Announce Their Partnership for Revenue Cycle Comparative Analytics Platform (ReCAP) for Member Hospitals


BOCA RATON, Fla., April 27, 2022 /PRNewswire/ -- Today, TPC and WhiteSpace Health announce their partnership to create a revenue cycle comparative analytics platform for TPC member hospitals located in Texas, Arkansas, Missouri, and Colorado.

Through this collaborative effort, TPC members will benefit from the innovative development of a platform that will provide revenue cycle benchmarking capabilities at both the aggregate and individual facility level and allow for analysis across each member hospital and physician enterprise.

According to TPC's Vice President of Revenue Cycle, Cody Waldrop, "TPC's vision is to deliver a revenue cycle comparative analytics platform that helps establish benchmarks for our members to compare and share KPIs and best practices. WhiteSpace's ability to aggregate and normalize data from multiple organizations and multiple systems is critical to our objective of identifying opportunities for improvement. TPC's goal is to provide our members with accurate business intelligence and help them make informed decisions that lead to high financial performance alongside productive and efficient operations."

"WhiteSpace Health's AI based Revenue Intelligence Platform enables health system CFOs and COOs to manage and improve the financial performance of their organizations," states Gautam Char, President, and CEO of WhiteSpace Health. "Delivering fresh KPIs and comparative analytics across the varied hospital and practice health record systems of TPC members is critical to understanding and improving their performance. Even greater value can be realized from the platform through the identification and resolution of complex issues that directly lift and accelerate revenue. The ML engine and rules within our platform provide the knowledge needed to ensure conversion of denials to cash." 

About TPC

TPC is a partnership of community-based healthcare providers that work together as a single system to aggregate business volume and leverage economies of scale without sacrificing individual independence or local ownership. By working through a committed platform, TCP drives collaboration and innovation across a range of clinical, operational, and economic areas enabling providers to maximize the financial and non-financial value they receive. TPC represents 16 acute care hospitals and approximately $1 billion in purchasing volume. TPC exists for the sole purpose of helping healthcare organizations remain strong and independent. For more information, visit www.tpc1.com or  https://www.linkedin.com/company/tpctogether.

About WhiteSpace Health

WhiteSpace Health is a deep analytics company whose Revenue Intelligence Platform supports the informational and decision-making needs across settings of care and scales to support some of the largest and most complex healthcare enterprises. The platform integrates with disparate systems to provide a unified enterprise dataset. Through the combination of artificial intelligence and proprietary methodologies, WhiteSpace Health securely delivers fresh, actionable insights that build organizational alignment through data, and support rapid decision making essential for resolving areas of revenue leakage, improving operational performance, uplifting revenue, and transforming the business. Additionally, new guided solutions enable both the prevention and resolution of denials, as well as predictive capabilities to reduce patient no-shows that drive higher provider utilization. Follow us on LinkedIn, Facebook and Twitter or visit us at www.whitespacehealth.com.

Media Contacts

Kelly Love
Vice President, Marketing & Communications
[email protected]
+1 469 ? 366.2136

Carrie M. Bauman
Vice President of Marketing and Communication
[email protected]
+1 919 ? 600.2417

SOURCE WhiteSpace Health


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: